血凝素(流感)
脂质体
脂质双层融合
免疫原性
病毒包膜
病毒
小干扰RNA
病毒载体
病毒学
化学
生物
核糖核酸
免疫系统
生物化学
基因
重组DNA
免疫学
作者
Yichen Wang,Bo Jin,Bao Li,Yucen Luo,Mengrui Ma,Yongfeng Chen,Hui Liu,Huichao Xie,Tianzhi Yang,Xiaoyun Zhao,Pingtian Ding
标识
DOI:10.1016/j.ijpharm.2022.121890
摘要
It is well known that the difficulty of siRNA therapeutic application is the lack of safe and effective delivery vector. Virosome is a nano vesicle composed of lipid membrane and membrane protein. It retains fusion protein without virus genetic material, and therefore has the reduced immunogenicity compared with viral vector. Virosomes have the potential to deliver protein and nucleic acid drugs, but the traditional preparation method of virosomes is quite limited. In this study, we firstly proposed to synthesize influenza virus hemagglutinin HA2 virosomes by cell-free protein synthesis. In this study, liposomes provided the hydrophobic lipid bilayer environment for the formation of HA2 protein multimer, which inhibited the aggregation of hydrophobic HA2 and improved HA2 protein expression. Chitosan as a rigid core adsorbed siRNA and improved the encapsulation efficiency of siRNA. In conclusion, the cell-free protein synthesis was used to prepare HA2 virosomes, which paves the way for constructing a novel nano vector with high delivery efficiency and biosafety for the delivery of siRNA.
科研通智能强力驱动
Strongly Powered by AbleSci AI